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Abstract
The aim of the research. To investigate the association of the development of primary open-angle glaucoma with deletion 
polymorphism of glutathione-S-transferase genes. 
Materials and methods. Under our observation there were 172 patients, residents of Ukraine with primary open-angle glau-
coma I–IV stages. Analysis of the deletion polymorphism of GSTM1 and GSTT1 genes was performed by real-time polymerase chain 
reaction using unified TaqMan Mutation Detection Assays Life-Technology (USA) test systems. Statistical analysis of the obtained data 
was performed using the MedStat package and the statistical package MedCalc v.15.1 (MedCalc Software bvba).
Results and discussion. The detection of null alleles of the GSTM1 gene was observed in 39 % of patients in the control group, 
in patients with POAG a significant increase in the frequency of deletion polymorphism to 50–56 % was observed with the progression 
of the disease in stages II–IV. In patients with stage IV disease, the effect of the zero GSTM1-null allele on POAG course was deter-
mined (χ2=3.97; p=0.047), and the null allele of GSTM1 doubled the probability of developing the disease (OR=2.01; 95 % CI=1.01–4.01) 
in patients of group 4 compared with control. The null allele of the GSTT1 gene in the control group was found in 31 %, an increase in 
the frequency of the GSTT1-null allele was also observed in the second and fourth stages of POAG from 41 % to 54 %. Statistically sig-
nificant differences of GSTT1 gene allele frequencies were determined between the control group and all patients with POAG (χ2=4.43; 
p=0.03), between the control and the 4th group (χ2=7.64; p=0.01), and between the 1st and 4th groups (χ2=5.52; p=0.02). An association 
with the development of POAG (χ2=4.43; p=0.03) was determined for the deletion polymorphism of the GSTT1 gene when comparing 
the control group with the data of all patients with POAG (1–4 groups). At stratification by stages of POAG (that is, by groups of pa-
tients), an association with the development of POAG was determined only in patients of group 4 (χ2=7.64; p=0.01) compared with the 
control group. 
Conclusions. The association of the null allele of the GSTT1 gene with POAG was established (p=0.03). The presence of the 
GSTT1-null allele significantly increased the risk of developing POAG (OR=1.75; BI=1.04–2.96) compared with the control group. 
The presence of null alleles (GSTM1-null and GSTT1-null) of the GST deletion polymorphism significantly increased the risk of 
stage IV POAG (OR=2.01; BI=1.01–4.01 and OR=2.66; VI=1.32–5.37, respectively) compared with the control group, which indicated 
the effect of zero alleles on the rapid progression of the disease.
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1. Introduction
Primary open-angle glaucoma (POAG) is widespread worldwide (accounting for 74 % in the 
overall structure of glaucoma) and in Ukraine (17.2 % in the general structure of vision patholo- 
gy) [1, 2]. The main problem is the lack of timely diagnosis, and therefore the effective treatment of 
the initial stages of glaucoma. POAG results in both reduced visual acuity and complete blindness. 
According to WHO, glaucoma ranks second among the diseases that are irreversibly cause blind-
ness and ranges from 0.6 % to 33.0 % [3, 4].
It has long been believed that in the pathogenesis of this disease the leading place is occu-
pied by an increase in intraocular pressure (IOP), but at the present stage POAG is attributed to 
multifactorial diseases [5, 6]. The risk factors for its development include: hypertension, smoking, 
diabetes, myopia, old age, hypothyroidism, dyscirculatory encephalopathy [7, 8]. In the pathogen-
esis of POAG, the activation of oxidative stress and glutamate excitotoxicity, which damage the 
retinal ganglion cells, endothelium, activate apoptosis, and impaired blood rheological properties 
and microcirculation, play a significant role [8, 9].
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In recent years, the evidence base for the involvement of hereditary factors has increased, 
and although POAG is not inherited by Mendel’s law, the risk of its development is significantly 
increased in offspring of patients with POAG [10, 11]. The association of 25 genes with the develop-
ment of the glaucomatous process has been determined [12, 13]. Particular attention is paid to genes 
that are related to the regulation of the processes of elimination of toxic substances and protection 
against oxidative damage. Such genes include genes that regulate glutathione-S-transferase (GST) 
synthesis. The family of these enzymes has eight classes: Alpha (GSTA), Mu (GSTM), Pi (GSTP), 
Theta GSTT), Kappa (GSTK), Zeta (GSTZ), Omega (GSTO) and Sigma (GSTS) [14, 15]. GST en-
zymes catalyze the conjugation of reduced glutathione, protect the body against toxic substances, 
reduce endogenous oxidative stress, and neutralize lipid and nucleic acid oxidation products [16]. 
It has been determined that the enzymatic activity of transcriptional proteins and GST directly 
depends on the deletion polymorphism of GSTM1 and GSTT1 genes, which are regulators of sec-
ond-phase xenobiotics biotransformation enzymes [17, 18].
The aim of the research. To investigate the association of the development of primary 
open-angle glaucoma with deletion polymorphism of glutathione-S-transferase genes.
2. Materials and methods
The study involved 172 patients with stage I-IV POAGs and various levels of IOP, who were 
examined at the Kyiv City Clinical Ophthalmic Hospital Center for Eye Microsurgery, the clinical 
base of the Shupyk National Medical Academy of Postgraduate Education. Used the classification 
of primary glaucoma A. P. Nesterov and A. Ya. Bunin (1976) and the classification of perimetric 
changes according to the stages of glaucoma. In the initial examination, patients were divided into 
four groups: group 1 – patients with initial stage POAG, group 2 – with advanced POAG, group 
3 – with further progression and narrowing of the visual field, group 4 – terminal, with the devel-
opment of blindness.
The studies were conducted in compliance with the main provisions of the Council of Eu-
rope Convention on Human Rights and Biomedicine, the World Health Association Helsinki Dec-
laration on Ethical Principles for Scientific Research with Human Involvement (1975, with further 
additions, including 1983 version) and MOH Order No. 690. All patients were familiarized with the 
purpose and objectives of the study. The control group consisted of 98 healthy volunteers who had 
no history of glaucoma disease. 
Samples of venous blood were collected for molecular genetic studies. Deletion polymor-
phism analysis of GSTM1 and GSTT1 genes was performed using real-time polymerase chain 
reaction (PCR) using unified TaqMan Mutation Detection Assays LifeTechnology (USA) test sys-
tems in the Gene Amp® PCR System 7500 automatic amplifier (USA). Statistical analysis of the 
obtained data was performed using the MedStat package and the statistical package MedCalc v.15.1 
(MedCalc Software bvba). The largest odds ratio (OR) was determined by the association of alleles 
or genotypes with a tendency to glaucoma. In all cases, the level of statistical significance was 
assumed to be 95 % (p<0.05).
3. Results 
The allelic polymorphism of the GSTM1 and GSTT1 genes in the control group and in pa-
tients with POAG was represented by the variants: homozygote 0/0 (null alleles), which completely 
deprives the enzyme of its activity, and heterozygote +/0. They are characterized by reduced en-
zymatic activity (so-called “slow conjugators”) and homozygotes +/+ that have normal glutathione 
transferase activity (a functionally active enzyme is synthesized). Therefore, the presence of zero 
alleles causes a decrease in enzyme activity and, accordingly, a failure of the body’s detoxification 
system [18].
The distribution of alleles of the GSTM1 gene in the control group and in patients of differ-
ent groups is given in Table 1.
Detection of null alleles of the GSTM1 gene was observed in 39 % of patients in the control 
group. In patients with POAG, a significant increase in the incidence of deletion polymorphism by 
up to 50–56 % was observed in the progression of the disease in stages II–IV. 
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Genes regulators of enzymes of the second phase of biotransformation of xenobiotics pro-
vide protection of the body against endogenous oxidative stress, exogenous toxins and neutralize 
lipid and nucleic acid oxidation products [16, 19]. Insufficiency of antioxidant protection systems in 
eye tissues, first of all – reduced glutathione, leads to intensification of oxidative stress with further 
development of neurodegeneration and apoptosis of retinal ganglion cells [20].
Our studies (Table 2) determined the effect of the GSTM1-null null allele on the POAG 
course (χ2=3.97; p=0.047), which was observed in patients with stage IV disease compared with 
the control group. In our opinion, this could be evidence of potentiation of disease progression in 
carriers of the GSTM1-null null allele.
Table 1
Distribution of GSTM1 gene allele frequency between groups 
Alleles Control Group 1 Group 2 Group 3 Group 4
GSTM1+
N 60 23 22 18 22
% 61 61 50 45 44
GSTM1-null
N 38 15 22 22 28
% 39 39 50 55 56
Total N 98 38 44 40 50
Table 2
Statistical significance of differences in the distribution of GSTM1 alleles between case-control groups
Control, group Cases, group χ2 df р
(χ2)
0 1+2+3+4 3.49 1 0.06
0 1 0.05 1 0.94
0 2 1.56 1 0.21
0 3 3.04 1 0.08
0 4 3.97 1 0.047
1 2 0.91 1 0.34
1 3 1.88 1 0.17
1 4 2.36 1 0.12
2 3 0.21 1 0.65
2 4 0.39 1 0.56
3 4 0.01 1 0.92
Note: χ2 – Pearson’s χ2-square test; df – number of freedom degrees; р
(χ2) – statistical significance of differences (if less than 0.05 
differences are significant)
Determining the magnitude of the odds ratio (OR), which characterizes the strength of the 
association with POAG (Table 3), showed that the null allele of GSTM1 doubled the likelihood of 
developing the disease (OR=2.01; 95 % BI=1.01–4, 01) in patients of the 4th group in comparison 
with the control. 
The null allele of the GSTT1 gene in the control group was found in 31 %, an increase 
in the frequency of the GSTT1-null allele was also observed in stage II–IV POAG from 41 % to 
54 % (Table 4).
The calculation of the frequencies of alleles of the GSTT1 gene in the control and experi-
mental groups are given in Table 5, where identified statistically significant differences between 
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the control group and all patients with POAG (χ2=4.43; p=0.03), between the control and 4 groups 
(χ2=7.64; p=0.01) and between the 1st and 4th groups (χ2=5.52; p=0.02). The GSTM1-null (0.39) 
zero allele frequencies found in our study are the same, and the GSTT1-null (0.31) frequencies are 
slightly higher in the European population according to 1000 Genomes Project Phase 3 (http://
www.internationalgenome.org/home). The frequency of the zero allele of the GSTM1 gene varies 
from 40 % to 60 % depending on the population and ethnic group. In Europe, the GSTT1 deletion 
polymorphism is found in 20 % of the population [15].
Table 3
Statistical significance of differences in GSTM1 gene allele frequency distribution between control group 
and group 4 and their degree of association with POAG
Alleles Group 4 n=50 Control n=98 χ2 р
(χ2) OR ±95 % ВІ
GSTM1+ 0.44 0.61
3.97 0.047
0.50 0.25-0.99
GSTM1-null 0.56 0.39 2.01 1.01-4.01
Note: χ2 – Pearson’s χ2-square test; р
(χ2) statistical significance of differences (if less than 0.05 differences are significant); OR – odds 
ratio; ±95 % ВІ – ±95 % probable interval for the OR value
Table 4
Frequency distribution of GSTT1 gene alleles between groups 
Alleles Control Group 1 Group 2 Group 3 Group 4
GSTT1+
N 68 27 26 21 23
% 69 71 59 53 46
GSTT1-null
N 30 11 18 19 27
% 31 29 41 47 54
Total N 98 38 44 40 50
Table 5
Statistical significance of differences in the distribution of GSTT1 alleles between “case-control” groups
Control, group Cases, group χ2 df р
(χ2)
0 1+2+3+4 4.43 1 0.03
0 1 0.04 1 0.85
0 2 1.43 1 0.23
0 3 3.53 1 0.06
0 4 7.64 1 0.01
1 2 1.27 1 0.26
1 3 2.83 1 0.09
1 4 5.52 1 0.02
2 3 0.37 1 0.54
2 4 1.61 1 0.20
3 4 0.38 1 0.54
Note: χ2 – Pearson’s χ2-square test; df – number of freedom degrees; р
(χ2) – statistical significance of differences (if less than 
0.05 differences are significant)
An association with the development of POAG (χ2=4.43; p=0.03) was determined for the 
deletion polymorphism of the GSTT1 gene (Table 6) when comparing the control group with the 
data of all patients with POAG (groups 1 to 4).
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At stratification by stages of POAG (that is, by groups of patients), an association with the 
development of POAG was determined (Table 7) only in patients of group 4 (χ2=7.64; p=0.01) com-
pared with the control group. 
Table 6
Statistical significance of differences in GSTT1 gene allele frequency distribution between control group and 
patients with POAG and their degree of association with POAG
Alleles POAG n=172 Control n=98 χ2 р
(χ2) OR ±95 % ВІ
GSTT1+ 0.56 0.69
4.43 0.03
0.57 0.34-0.96
GSTT1-null 0.44 0.31 1.75 1.04-2.96
Note: χ2 – Pearson’s χ2-square test; р
(χ2) – statistical significance of differences (if less than 0.05 differences are significant); OR – 
odds ratio; ±95 % ВІ – ±95 % probable interval for the OR value
Table 7
Statistical significance of differences in GSTT1 gene allele frequency distribution between control and group 
4 patients and their degree of association with POAG
Alleles Group 4 n=50 Control n=98 χ2 р
(χ2) OR ±95 % ВІ
GSTT1+ 0.46 0.69
7.64 0.01
0.38 0.19-0.76
GSTT1-null 0.54 0.31 2.66 1.32-5.37
Note: χ2 – Pearson’s χ2-square test; р
(χ2) – statistical significance of differences (if less than 0.05 differences are significant); OR – 
odds ratio; ±95 % ВІ – ±95 % probable interval for the OR value
4. Discussion
Studies that considered POAG in different ethnic groups have suggested that deletion 
polymorphisms of GSTM1 and GSTT1 can either increase or decrease the risk of POAG or do 
not confirm any association with the disease [16]. The obtained data in our study indicated 
that there was a negative association of GSTT1 and GSTM1 deletion polymorphisms with the 
development of POAG. It is likely that the accumulation of toxic metabolites in the eye tissues 
due to a decrease in glutathione transferase activity contributes to tissue damage and leads to 
a deepening of the drainage of the aqueous humour of the eye.
Study limitations. The study was not conducted in case of identified concomitant pa-
thology of eyes or another organs.
Perspective of further research. Determination of the role of deletion polymor-
phism of glutathione-S-transferase genes in POAG development and progression will pro-
vide an opportunity to evaluate the risk of POAG development and it’s stages depending on 
the relevant genotype. As a result of the research, a mathematical model will be designed 
and can be used in practical ophthalmology to determine an individual treatment strategy 
of POAG.
5. Conclusions
The association of the zero allele of the GSTT1 gene with the development of primary 
open-angle glaucoma (p=0.03) was established.
The presence of the GSTT1-null allele significantly increased the risk of developing 
POAG (OR=1.75; CI=1.04–2.96) compared with the control group
The presence of null alleles (GSTM1-null and GSTT1-null) of the deletion polymor-
phism of the GST gene significantly increased the risk of stage IV POAG (OR=2.01; BI= 
=1.01–4.01 and OR=2.66; BI=1.32–5.37, respectively) compared with the control group, which 
indicated the effect of zero alleles on the rapid progression of the disease.
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